KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Interest Expenses (2022 - 2025)

Teladoc Health (TDOC) has disclosed Interest Expenses for 4 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 27.7% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.7 million through Dec 2025, down 17.18% year-over-year, with the annual reading at $19.7 million for FY2025, 17.18% down from the prior year.
  • Interest Expenses hit $5.0 million in Q4 2025 for Teladoc Health, up from $4.5 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $6.8 million in Q4 2024 to a low of $4.5 million in Q2 2025.
  • Historically, Interest Expenses has averaged $5.5 million across 4 years, with a median of $5.6 million in 2023.
  • Biggest five-year swings in Interest Expenses: increased 23.62% in 2024 and later dropped 27.7% in 2025.
  • Year by year, Interest Expenses stood at $4.6 million in 2022, then grew by 20.68% to $5.5 million in 2023, then rose by 23.62% to $6.8 million in 2024, then decreased by 27.7% to $5.0 million in 2025.
  • Business Quant data shows Interest Expenses for TDOC at $5.0 million in Q4 2025, $4.5 million in Q3 2025, and $4.5 million in Q2 2025.